Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 5.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,025,671 shares of the company's stock after buying an additional 101,823 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.25% of Colgate-Palmolive worth $185,714,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in CL. Vanguard Group Inc. boosted its holdings in Colgate-Palmolive by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company's stock valued at $6,633,570,000 after purchasing an additional 1,026,985 shares during the period. Geode Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company's stock worth $1,754,657,000 after purchasing an additional 304,426 shares during the period. Morgan Stanley raised its position in shares of Colgate-Palmolive by 1.7% in the fourth quarter. Morgan Stanley now owns 19,246,217 shares of the company's stock valued at $1,520,836,000 after buying an additional 323,367 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company's stock valued at $1,240,652,000 after buying an additional 1,010,872 shares during the period. Finally, Norges Bank bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $861,670,000. Institutional investors own 80.41% of the company's stock.
Insiders Place Their Bets
In other Colgate-Palmolive news, Director John T. Cahill sold 4,170 shares of the company's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director owned 28,373 shares of the company's stock, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Noel R. Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the sale, the chief executive officer directly owned 362,231 shares in the company, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.43% of the company's stock.
Colgate-Palmolive Trading Down 1.9%
CL opened at $90.22 on Tuesday. The company's 50 day moving average is $91.76 and its 200-day moving average is $90.05. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The company has a market cap of $71.92 billion, a P/E ratio of 35.80, a PEG ratio of 4.48 and a beta of 0.33.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.36 billion during the quarter, compared to the consensus estimate of $5.36 billion. During the same quarter in the prior year, the firm earned $0.92 EPS. The firm's revenue was up 4.9% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive Company will post 3.86 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, July 20th were issued a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive's dividend payout ratio (DPR) is 84.13%.
Wall Street Analyst Weigh In
CL has been the topic of a number of recent research reports. Sanford C. Bernstein restated a "market perform" rating on shares of Colgate-Palmolive in a research note on Thursday. Morgan Stanley reiterated an "overweight" rating and set a $104.00 target price on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Wells Fargo & Company increased their target price on Colgate-Palmolive from $92.00 to $95.00 and gave the stock an "equal weight" rating in a report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $104.00 to $103.00 and set an "overweight" rating for the company in a research note on Monday, August 3rd. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $99.00.
View Our Latest Stock Analysis on CL
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report